{"id":"NCT01256450","sponsor":"BioDelivery Sciences International","briefTitle":"Efficacy and Safety Study of Buprenorphine HCl Buccal Film in Subjects With Low Back Pain","officialTitle":"A 12-Week, Placebo Controlled, Double Blind, Randomized Withdrawal Study to Evaluate the Efficacy and Safety of Buprenorphine HCl Buccal Film in Subjects With Moderate to Severe Chronic Low Back Pain","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-11","primaryCompletion":"2011-07","completion":"2011-07","firstPosted":"2010-12-08","resultsPosted":"2015-12-08","lastUpdate":"2017-02-27"},"enrollment":334,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Pain","Low Back Pain"],"interventions":[{"type":"DRUG","name":"Buprenorphine","otherNames":["buprenorphine buccal soluble film","BEMA Buprenorphine","BELBUCA","buprenorphine HCl buccal film"]},{"type":"DRUG","name":"Placebo","otherNames":["Placebo buccal soluble film","Placebo buccal film","BEMA placebo"]}],"arms":[{"label":"BEMA Buprenorphine","type":"EXPERIMENTAL"},{"label":"BEMA Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine whether buprenorphine hydrochloride (HCl) buccal film is effective and safe in the treatment of chronic low back pain (CLBP).","primaryOutcome":{"measure":"Change in Pain Intensity From Baseline to Week 12","timeFrame":"Baseline, Week 12","effectByArm":[{"arm":"DB Buprenorphine HCl Buccal Film","deltaMin":0.33,"sd":1.944},{"arm":"DB Placebo Film","deltaMin":0.46,"sd":2.093}],"pValues":[{"comp":"OG000 vs OG001","p":".5870"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":8},"locations":{"siteCount":24,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":330},"commonTop":["NAUSEA","HEADACHE","CONSTIPATION","DIZZINESS","VOMITING"]}}